GGrantIndex
← Search

PHASE I CLINICAL TRIAL OF 17-ALLYLAMINO-17-DEMETHOXY-GELDANAMYCIN (KOS-953)

$968M01FY2007RRNIH

University Of Southern California, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →